Research output per year
Research output per year
Fingerprint
Dive into the research topics where Section of Molecular Oncology & Developmental Therapeutics is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis
Krishnamurthy, J., Luo, J., Suresh, R., Ademuyiwa, F., Rigden, C., Rearden, T., Clifton, K., Weilbaecher, K., Frith, A., Roshal, A., Tandra, P. K., Cherian, M., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L., Bergqvist, M., Peterson, L. & Ma, C. X., Dec 2022, In: npj Breast Cancer. 8, 1, 35.Research output: Contribution to journal › Article › peer-review
Open Access -
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Costello, B. A., Bhavsar, N. A., Zakharia, Y., Pal, S. K., Vaishampayan, U., Jim, H., Fishman, M. N., Molina, A. M., Kyriakopoulos, C. E., Tsao, C. K., Appleman, L. J., Gartrell, B. A., Hussain, A., Stadler, W. M., Agarwal, N., Pachynski, R. K., Hutson, T. E., Hammers, H. J., Ryan, C. W., Mardekian, J., & 3 others, Feb 2022, In: Clinical Genitourinary Cancer. 20, 1, p. 1-10 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma
Damato, A. R., Katumba, R. G. N., Luo, J., Atluri, H., Talcott, G. R., Govindan, A., Slat, E. A., Weilbaecher, K. N., Tao, Y., Huang, J., Butt, O. H., Ansstas, G., Johanns, T. M., Chheda, M. G., Herzog, E. D., Rubin, J. & Campian, J., May 1 2022, In: Neuro-Oncology Practice. 9, 3, p. 193-200 8 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations